Please login to the form below
Gene testing
This page shows the latest Gene testing news and features for those working in and with pharma, biotech and healthcare.
AbbVie, Biogen and Pfizer collaboration creates new resource for genetic exome sequence analysis
Working with the Broad Institute, the three companies completed data processing and conducted single variant and gene-based association testing with nearly 4, 000 UK Biobank phenotypes.
Latest news
-
Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy
Project will aim to discover and develop a gene therapy for sickle cell disease. ... Current gene therapies in clinical testing for SCD work by taking cells from a patient that are then altered in a laboratory and reintroduced to the patient in a process
-
AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
As part of this first deal, Voyager received $69m upfront to advance gene therapy candidates into phase 1 testing, with AbbVie gaining the option to license one or more for further ... In 2019, French drugmaker Sanofi also scaled back on a gene therapy
-
Astellas makes gene therapy a core focus with $3bn Audentes buy
Meanwhile, Audentes has several other candidates in development, including therapies for Pompe disease, Duchenne muscular dystrophy and myotonic dystrophy that are being prepared for clinical testing. ... It’s not the first gene therapy deal the
-
UniQure gets speedy US review for Huntington’s gene therapy
vector carrying gene designed to reduce levels of an overexpressed protein in Huntington’s disease. ... We are nearing the initiation of a phase 1/2 study of AMT-130, the first one-time administered AAV gene therapy to enter clinical testing for
-
Editas CEO exits the CRISPR firm ahead of first clinical trial
EDIT-101 is also expected to become the of Editas’ gene-editing medicines to start clinical testing, as the company recently got approval for an Investigational New Drug (IND) application for ... EDIT-101 is designed to be delivered directly into the
Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy
AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
Astellas makes gene therapy a core focus with $3bn Audentes buy
UniQure gets speedy US review for Huntington’s gene therapy
Editas CEO exits the CRISPR firm ahead of first clinical trial
More from news
Approximately 1 fully matching, plus 17 partially matching documents found.
Latest Intelligence
-
Cell and gene therapy
And even for allogeneic cell therapies and gene therapies, raw materials and analytical testing costs will also need to be reduced” Davies said. ... As a result, Lonza’s efforts to reduce cell and gene therapy production costs involve logistics, said
Cell and gene therapy
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Realizing the Potential of Genomics-Driven Precision Medicine
Jennifer Helfer, Senior Director, Patient Advocacy &Engagement at Encoded Therapeutics Inc., discusses genomics-driven precision medicine, gene therapy misconceptions and fears, involving patients and caregivers in designing gene therapy trials, how
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Rocky start for Biogen’s Alzheimer’s drug Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
- Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
- US demand for COVID-19 antibody treatments rising fast
- Our mission: helping patients in areas of unmet medical need
- Novo Nordisk settles US insulin pricing dispute for $100m
- Mysterious big pharma company eyes US biotech Acceleron
- COVID-19 changed change and communications will never be the same
- Understanding behaviour change: A Porterhouse Insights specialism
- Lynparza significantly delays disease progression as first-line treatment in prostate cancer
- David Hunt launches independent agency The Considered
- Live Webinar: Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- Lucid Group celebrates a double win at Communiqué 2021
- China backs use of Roche’s Actemra for coronavirus
- Future of MHRA uncertain amid Brexit-fuelled shake up
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- Understanding behaviour change: A Porterhouse Insights specialism
- ...
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
